Improving dermatology outcomes through gene expression profiling
Castle Biosciences is focused on transforming disease management through molecular tests that provide clinically actionable information to clinicians and patients. The company’s portfolio of dermatologic tests use the gene expression profile of a patient’s tumor to provide a personalized assessment of risk that guides treatment decisions and helps improve outcomes. Castle engaged HDMZ to develop a revived brand identity for their dermatologic tests. The brand was then used as the foundation of a new and improved website and brought to life through an omni-channel media and digital marketing plan targeted to clinicians and patients across paid, earned, social, and organic channels. HDMZ also developed a new booth design to introduce Castle’s dermatologic portfolio at the American Academy of Dermatology conference.